Microscopic and Biochemical Hallmarks of BICD2-Associated Muscle Pathology toward the Evaluation of Novel Variants

BICD2 variants have been linked to neurodegenerative disorders like spinal muscular atrophy with lower extremity predominance (SMALED2) or hereditary spastic paraplegia (HSP). Recently, mutations in BICD2 were implicated in myopathies. Here, we present one patient with a known and six patients with novel BICD2 missense variants, further characterizing the molecular landscape of this heterogenous neurological disorder. A total of seven patients were genotyped and phenotyped. Skeletal muscle biopsies were analyzed by histology, electron microscopy, and protein profiling to define pathological hallmarks and pathogenicity markers with consecutive validation using fluorescence microscopy. Clinical and MRI-features revealed a typical pattern of distal paresis of the lower extremities as characteristic features of a BICD2-associated disorder. Histological evaluation showed myopathic features of varying severity including fiber size variation, lipofibromatosis, and fiber splittings. Proteomic analysis with subsequent fluorescence analysis revealed an altered abundance and localization of thrombospondin-4 and biglycan. Our combined clinical, histopathological, and proteomic approaches provide new insights into the pathophysiology of BICD2-associated disorders, confirming a primary muscle cell vulnerability. In this context, biglycan and thrombospondin-4 have been identified, may serve as tissue pathogenicity markers, and might be linked to perturbed protein secretion based on an impaired vesicular transportation.

[1]  C. Depienne,et al.  Proteomic and morphological insights and clinical presentation of two young patients with novel mutations of BVES (POPDC1). , 2022, Molecular genetics and metabolism.

[2]  C. Hoogenraad,et al.  Loss of BICD2 in muscle drives motor neuron loss in a developmental form of spinal muscular atrophy , 2019, Acta Neuropathologica Communications.

[3]  B. Wirth,et al.  Novel insights into SMALED2: BICD2 mutations increase microtubule stability and cause defects in axonal and NMJ development , 2018, Human molecular genetics.

[4]  C. Dauphin,et al.  Truncating mutations on myofibrillar myopathies causing genes as prevalent molecular explanations on patients with dilated cardiomyopathy , 2017, Clinical genetics.

[5]  C. Hetz,et al.  The Unfolded Protein Response and Cell Fate Control. , 2017, Molecular cell.

[6]  Keith Nykamp,et al.  Sherloc: a comprehensive refinement of the ACMG–AMP variant classification criteria , 2017, Genetics in Medicine.

[7]  R. Vale,et al.  Disease-associated mutations in human BICD2 hyperactivate motility of dynein–dynactin , 2017, bioRxiv.

[8]  A. Ferbert,et al.  Expanding the phenotype of BICD2 mutations toward skeletal muscle involvement , 2016, Neurology.

[9]  J. Molkentin,et al.  Thrombospondin expression in myofibers stabilizes muscle membranes , 2016, eLife.

[10]  C. Hoogenraad,et al.  Cytoplasmic dynein and its regulatory proteins in Golgi pathology in nervous system disorders , 2015, Front. Neurosci..

[11]  F. Muntoni,et al.  Phenotypic and molecular insights into spinal muscular atrophy due to mutations in BICD2. , 2015, Brain : a journal of neurology.

[12]  B. Wirth,et al.  Dominant spinal muscular atrophy due to BICD2: a novel mutation refines the phenotype , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[13]  J. Veltman,et al.  Mutations in BICD2, which encodes a golgin and important motor adaptor, cause congenital autosomal-dominant spinal muscular atrophy. , 2013, American journal of human genetics.

[14]  B. Asselbergh,et al.  Molecular defects in the motor adaptor BICD2 cause proximal spinal muscular atrophy with autosomal-dominant inheritance. , 2013, American journal of human genetics.

[15]  D. MacArthur,et al.  Mutations in BICD2 cause dominant congenital spinal muscular atrophy and hereditary spastic paraplegia. , 2013, American journal of human genetics.

[16]  A. Hyman,et al.  BICD2, dynactin, and LIS1 cooperate in regulating dynein recruitment to cellular structures , 2012, Molecular biology of the cell.

[17]  L. Mei,et al.  Biglycan Is an Extracellular MuSK Binding Protein Important for Synapse Stability , 2012, The Journal of Neuroscience.

[18]  C. Hoogenraad,et al.  Pericentrosomal targeting of Rab6 secretory vesicles by Bicaudal-D-related protein 1 (BICDR-1) regulates neuritogenesis , 2010, The EMBO journal.

[19]  Ilya Grigoriev,et al.  Rab6 regulates transport and targeting of exocytotic carriers. , 2007, Developmental cell.

[20]  C. I. Zeeuw,et al.  Bicaudal-D regulates COPI-independent Golgi–ER transport by recruiting the dynein–dynactin motor complex , 2002, Nature Cell Biology.

[21]  M. Pericak-Vance,et al.  A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10). , 2002, American journal of human genetics.

[22]  C. Preisinger,et al.  The Rab6 GTPase Regulates Recruitment of the Dynactin Complex to Golgi Membranes , 2002, Current Biology.

[23]  C. Hoogenraad,et al.  Mammalian Golgi‐associated Bicaudal‐D2 functions in the dynein–dynactin pathway by interacting with these complexes , 2001, The EMBO journal.

[24]  P. Caroni,et al.  Thrombospondin-4, an extracellular matrix protein expressed in the developing and adult nervous system promotes neurite outgrowth , 1995, The Journal of cell biology.

[25]  Ada T Feldman,et al.  Tissue processing and hematoxylin and eosin staining. , 2014, Methods in molecular biology.

[26]  D. MacArthur,et al.  Mutations in BICD 2 Cause Dominant Congenital Spinal Muscular Atrophy and Hereditary Spastic Paraplegia , 2013 .